171 related articles for article (PubMed ID: 6434393)
1. Pharmacogenetic perspectives: genes, drugs and disease.
Vesell ES
Hepatology; 1984; 4(5):959-65. PubMed ID: 6434393
[No Abstract] [Full Text] [Related]
2. Pharmacogenetic approaches to the prediction of drug response.
Vesell ES
NIDA Res Monogr; 1986; 66():25-40. PubMed ID: 3106816
[No Abstract] [Full Text] [Related]
3. [Genetic causes for the variability of effects and side effects of drugs].
Roots I
Internist (Berl); 1982 Nov; 23(11):601-9. PubMed ID: 6759450
[No Abstract] [Full Text] [Related]
4. Pharmacogenetic polymorphism of drug metabolism.
Paxton JW
N Z Med J; 1984 Aug; 97(762):567-9. PubMed ID: 6591031
[No Abstract] [Full Text] [Related]
5. Inherited defects of hepatic drug metabolism.
Küpfer A; Preisig R
Semin Liver Dis; 1983 Nov; 3(4):341-54. PubMed ID: 6417793
[No Abstract] [Full Text] [Related]
6. Drugs and genes.
Motulsky AG
Ann Intern Med; 1969 Jun; 70(6):1269-72. PubMed ID: 4182785
[No Abstract] [Full Text] [Related]
7. Genes encoding drug-metabolizing enzymes: possible role in human disease.
Nebert DW
Basic Life Sci; 1988; 43():45-64. PubMed ID: 2896496
[No Abstract] [Full Text] [Related]
8. [Pharmacogenetics, its achievements and perspectives (review of the literature)].
Skakun NP
Vrach Delo; 1974 Mar; (3):1-4. PubMed ID: 4619733
[No Abstract] [Full Text] [Related]
9. Molecular genetics of the debrisoquin-sparteine polymorphism.
Gonzalez FJ; Meyer UA
Clin Pharmacol Ther; 1991 Sep; 50(3):233-8. PubMed ID: 1680592
[No Abstract] [Full Text] [Related]
10. Ethnic differences in reactions to drugs and xenobiotics. Other protein variants with pharmacogenetic consequences: albumin and orosomucoid.
Alván G
Prog Clin Biol Res; 1986; 214():345-55. PubMed ID: 3523512
[No Abstract] [Full Text] [Related]
11. [Basic problems and tasks of clinical pharmacogenetics].
Skakun NP
Klin Med (Mosk); 1980 Jan; 58(1):11-6. PubMed ID: 6988636
[No Abstract] [Full Text] [Related]
12. [Genetic polymorphism of the hepatic metabolism of drugs].
Larrey D; Pessayre D; Benhamou JP
Gastroenterol Clin Biol; 1985; 9(6-7):522-31. PubMed ID: 3926587
[No Abstract] [Full Text] [Related]
13. [The HLA gene complex].
Mayr WR
Infusionsther Transfusionsmed; 1994 Jun; 21(3):185-91. PubMed ID: 7919906
[TBL] [Abstract][Full Text] [Related]
14. [Genetic polymorphism of drug oxidation].
Heller FR; Leclercq V; Harvengt C
Acta Gastroenterol Belg; 1988; 51(1):91-101. PubMed ID: 3055790
[No Abstract] [Full Text] [Related]
15. Genetic and environmental factors affecting drug response in man.
Vesell ES
Fed Proc; 1972; 31(4):1253-69. PubMed ID: 4114107
[No Abstract] [Full Text] [Related]
16. Molecular biology of the HLA class I and class II genes.
Wake CT
Mol Biol Med; 1986 Feb; 3(1):1-11. PubMed ID: 3083191
[TBL] [Abstract][Full Text] [Related]
17. Polymorphic differences in drug metabolism and response.
Vetticaden SJ
Methods Find Exp Clin Pharmacol; 1988 Aug; 10(8):531-6. PubMed ID: 3067018
[TBL] [Abstract][Full Text] [Related]
18. Molecular mechanisms of genetic polymorphisms of drug metabolism.
Meyer UA; Zanger UM
Annu Rev Pharmacol Toxicol; 1997; 37():269-96. PubMed ID: 9131254
[TBL] [Abstract][Full Text] [Related]
19. Polymorphism of human cytochrome P450 enzymes and its clinical impact.
Zhou SF; Liu JP; Chowbay B
Drug Metab Rev; 2009; 41(2):89-295. PubMed ID: 19514967
[TBL] [Abstract][Full Text] [Related]
20. Poor metabolisers of debrisoquine reveal their true colours.
Idle JR
Lancet; 1989 Nov; 2(8671):1097. PubMed ID: 2572815
[No Abstract] [Full Text] [Related]
[Next] [New Search]
